- Infusion Pumps
- Metered Dose Inhalers
- Ocular Inserts
- Nasal Sprays
- Implantable Drug Delivery Devices
- Transdermal Patches
- Trans-Mucosal Drug Delivery Devices
Asia Pacific Drug Delivery Devices Market size was valued at USD 228.4 million in 2021 and is expected to reach USD 371.6 million by 2028, at a CAGR of 7.2% from 2023 to 2029. Drug delivery devices are used to deliver the drugs or chemical substances into the body for therapeutic effects by using different formulations, technologies, and approaches. These devices can be used for diagnosis, treatment, cure, or prevent various diseases such as diabetes, autoimmune disorders, bacterial and viral infections, and allergies among others. Various medicinal formulations such as antibiotics and insulin are most commonly administered by using these devices to increase the efficiency of drug by controlling dosage, time, and release the drug at specific site in the body.
Drivers: Increase in the prevalence of chronic diseases such as diabetes and cancerin China, India, and Japan Adoption of newer drug delivery devices and acquisitions between the market players Rise in awareness about self-injector devices and development in healthcare expenditure
Restraints: Stringent regulation for the approval of drug delivery devices Product recalls and Complications in the use of drug delivery devices such as dosage errors High cost of drug delivery devices
2021 is the base year and 2028 is the forecast year.
The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).
In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.